Related Experiment Video
Updated: Apr 27, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.6K
Left atrial appendage closure devices
Jorge Romero1, Irving E Perez1, Andrew Krumerman1
1Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, Bronx, NY, USA.
Clinical Medicine Insights. Cardiology
|June 26, 2014
Summary
Atrial fibrillation (AF) stroke risk is high, often from the left atrial appendage (LAA). LAA occlusion offers an alternative to anticoagulants, with this review examining current techniques and safety data.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Atrial fibrillation (AF) significantly elevates thromboembolic stroke risk (5-fold).
- The left atrial appendage (LAA) is the primary source of thrombus in AF-related strokes.
- Current oral anticoagulation therapies have limitations like bleeding risk and compliance issues.
Purpose of the Study:
- To review emerging techniques and devices for left atrial appendage (LAA) occlusion.
- To evaluate the efficacy and safety of LAA occlusion based on published literature.
Main Methods:
- Literature review of studies on LAA occlusion devices and techniques.
- Analysis of efficacy and safety data from clinical trials and observational studies.
Main Results:
- LAA occlusion is presented as a viable alternative to oral anticoagulation for stroke prevention in AF.
- Efficacy and safety profiles of various LAA occlusion strategies are discussed.
Conclusions:
- Left atrial appendage occlusion is a promising therapeutic option for reducing stroke risk in patients with atrial fibrillation.
- Further research and data are crucial for optimizing LAA occlusion techniques and device selection.
